Daejeon, South Korea

In Pyo Choi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: In Pyo Choi: Innovator in Natural Killer Cell Production

Introduction

In Pyo Choi is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of natural killer (NK) cells. With a total of three patents to his name, Choi's work focuses on innovative methods that enhance the therapeutic potential of NK cells in cancer treatment.

Latest Patents

Choi's latest patents include a method for producing natural killer cells using direct reprogramming. This invention relates to the generation of NK cells that exhibit excellent proliferative potential and cancer cell killing capabilities. The method also encompasses a biomarker specific to the NK cells, a cell therapeutic agent comprising these cells, and a composition for the treatment and prevention of cancer. Additionally, he has developed a method for mass-producing NK cells, which can be utilized as an anti-cancer agent. This method allows for the production of fresh NK cells with high purity in a short time, as well as cold-preserved and thawed cryopreserved NK cells that maintain efficacy comparable to fresh NK cells. These innovations demonstrate the potential of NK cells as effective cellular therapeutic agents against various cancers.

Career Highlights

Choi has worked with notable institutions such as the Korea Research Institute of Bioscience and Biotechnology and Seoul National University. His research has significantly advanced the understanding and application of NK cells in cancer therapy.

Collaborations

Choi has collaborated with colleagues including Sooyun Lee and Tae-Don Kim, contributing to the collective effort in advancing NK cell research and applications.

Conclusion

In Pyo Choi's innovative work in the field of natural killer cell production showcases his commitment to improving cancer treatment methodologies. His patents reflect a deep understanding of cellular therapies and their potential impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…